China's military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics <6185.HK> after clinical trials proved it was safe and somewhat efficient, the company said on Monday. The Ad5-nCoV is one of the eight vaccine candidates being developed by Chinese companies and researchers approved to be moved into human trials for the respiratory disease caused by the new coronavirus. China's Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year, CanSino said in a filing.




Source: CanSino's COVID-19 vaccine candidate approved for military use in China